Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
OTLK
$0.67
-11.07%
OTLK · Outlook Therapeutics, Inc.
$0.67
-0.08 (-11.07%)
At close · Aug 17
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$91.42M
Shares
120.86M
All earnings calls
Earnings call · FY2026 Q3
Outlook Therapeutics, Inc. Q3 FY2026 Earnings Call
Outlook Therapeutics, Inc. Q3 FY2026 Earnings Call
Research coverage
1 live source
Switch sources without leaving this page or losing your listening position.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 12, 2026 · complete as-filed document